HITLAB announced today the appointment of Divya Verma, Vice President of Business Development at Accord Healthcare, as the new Chair of its Women’s Health Tech Initiative (WHTI)—a major step forward in accelerating innovation for one of the most underfunded and underserved sectors of global healthcare.
Woddle is an AI-enabled infant health monitoring platform that integrates medical-grade weight measurement with intelligent, caregiver- and clinician-friendly support tools. At its core, Woddle is a smart changing pad with a built-in scale accurate to ±5 grams, paired with a connected mobile application that seamlessly captures and
analyzes infant data—including growth, feeding, and sleep patterns— to deliver real-time, reliable insights.
Caring for someone with dementia is one of the most challenging responsibilities a family member can face. From managing medications and coordinating appointments to navigating benefits and addressing behavioral changes, family caregivers often feel overwhelmed, unprepared, and isolated. Many struggle to access the right support at the right time, leading to increased stress, delayed care decisions, and gaps in the quality of care provided at home.
HITLAB announced today the launch of a new weekly Tuesday virtual series, called Breakthrough Tech Tuesdays, designed to highlight evidence-based healthcare innovation and its real-world clinical impact. This series, which is free and open to all, takes place every Tuesday, bringing together global health technology leaders, researchers, and healthcare executives for timely and applied discussions.
Every January, JP Morgan Health Week provides a clear view of where healthcare innovation stands. In 2026, the message was clear: the market now rewards results, not just ambition.
In talks with health system leaders, life-science executives, investors, and innovators, one theme kept coming up. Healthcare innovation has entered an era of accountability, where credibility comes from execution, evidence, and performance – not just promises.
Clinical trials are essential for advancing new therapies, yet traditional models remain slowed by high operational costs, long timelines, and limited patient access—challenges compounded by the fact that over 80% of trials occur in a small cluster of countries. Digital technologies now enable decentralized and hybrid approaches that expand geographic reach, improve participant diversity, and enhance trial efficiency through tools such as remote monitoring, telehealth, and mobile engagement.





